Try our Advanced Search for more refined results

Human Genome's Poison Pill Survives As GSK Eyes Coup

By Liz Hoffman (May 31, 2012, 2:24 PM EDT) -- Biotech company Human Genome Sciences Inc. beat a legal challenge to the poison pill it is using to fend off a $2.6 billion hostile takeover by GlaxoSmithKline PLC on Thursday, even as reports came that GSK was planning to replace the board of its unwilling target....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!